More recently, mutations in components of the NO/sGC pathway, especially in the sGC gene (GUCY1A3), have been linked to an increased CV risk, including myocardial infarction, coronary artery disease and HTN [24]. This evidence concerns the gene SGCB and myocardial infarction.